The post Nasdaq-Listed Firm Pivots to DAT Strategy With TON Focus; Scaramucci Joins as Advisor appeared on BitcoinEthereumNews.com. AlphaTON Capital Corp., formerly Portage Biotech Inc., has announced a financing initiative to acquire approximately $100 million in TON tokens and establish a digital asset treasury (DAT) focused on Telegram’s ecosystem. Anthony Scaramucci to Advise AlphaTON’s Toncoin Treasury Initiative The company stated on Wednesday that it will raise about $38.2 million through a private placement […] Source: https://news.bitcoin.com/nasdaq-listed-firm-pivots-to-dat-strategy-with-ton-focus-scaramucci-joins-as-advisor/The post Nasdaq-Listed Firm Pivots to DAT Strategy With TON Focus; Scaramucci Joins as Advisor appeared on BitcoinEthereumNews.com. AlphaTON Capital Corp., formerly Portage Biotech Inc., has announced a financing initiative to acquire approximately $100 million in TON tokens and establish a digital asset treasury (DAT) focused on Telegram’s ecosystem. Anthony Scaramucci to Advise AlphaTON’s Toncoin Treasury Initiative The company stated on Wednesday that it will raise about $38.2 million through a private placement […] Source: https://news.bitcoin.com/nasdaq-listed-firm-pivots-to-dat-strategy-with-ton-focus-scaramucci-joins-as-advisor/

Nasdaq-Listed Firm Pivots to DAT Strategy With TON Focus; Scaramucci Joins as Advisor

AlphaTON Capital Corp., formerly Portage Biotech Inc., has announced a financing initiative to acquire approximately $100 million in TON tokens and establish a digital asset treasury (DAT) focused on Telegram’s ecosystem. Anthony Scaramucci to Advise AlphaTON’s Toncoin Treasury Initiative The company stated on Wednesday that it will raise about $38.2 million through a private placement […]

Source: https://news.bitcoin.com/nasdaq-listed-firm-pivots-to-dat-strategy-with-ton-focus-scaramucci-joins-as-advisor/

Market Opportunity
TONCOIN Logo
TONCOIN Price(TON)
$1.704
$1.704$1.704
+1.06%
USD
TONCOIN (TON) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.